DYT-GNAL
Summary[edit]
- DYT-GNAL is a mostly adult-onset isolated dystonia (in which no additional neurologic abnormalities other than tremor are evident on neurologic examination). [1][1].
- The dystonia is most commonly focal and segmental, and rarely generalized.
- Dystonia is typically cervical in onset and commonly progresses to the cranial region (oromandibular/jaw, larynx, eyelids) and/or to one arm.
- DYT-GNAL tremor may be dystonic (i.e., occurring in a body part that shows at least minimal signs of dystonia) and may precede or follow the onset of dystonia).
Cause[edit]
DYT-GNAL caused by a heterozygous GNAL pathogenic variant has been reported in more than 60 individuals to date.
Inheritance[edit]

DYT-GNAL is typically inherited in an autosomal dominant manner (to date, 1 family with autosomal recessive inheritance of DYT-GNAL has been reported).
Signs and symptoms[edit]
DYT-GNAL is characterized by the following:
- Isolated; no neurologic abnormalities other than tremor evident on neurologic examination
- Age at onset typically in adulthood; rarely in childhood.
- Most commonly focal and segmental; rarely generalized ; and rarely laryngeal dystonia only.
- Onset typically in the cervical region and commonly progressing to the cranial region (oromandibular/jaw, larynx, blepharospasm) and/or to one arm
Diagnosis[edit]
DYT-GNAL should be considered in individuals with the following clinical findings, neuroimaging findings, and family history.[2][2]. Neuroimaging Studies
- Brain magnetic resonance imaging and computed tomography results are normal, showing no structural intracranial lesions that could be considered a cause of acquired dystonia.
The diagnosis of DYT-GNAL is established in a proband with isolated dystonia and a heterozygous GNAL pathogenic variant identified by molecular genetic testing.
Treatment[edit]
- While oral medication is usually the initial treatment of dystonia, experience in DYT-GNAL specifically is limited.
- Botulinum toxin intramuscular injections have improved cervical dystonia and dystonia affecting other sites in some patients with DYT-GNAL – as well as dystonia in selected muscles in patients with generalized dystonia.
- Deep-brain stimulation of the globus pallidus internus has been effective in a few patients with DYT-GNAL.
- Physical therapy may help prevent joint contractures and spine deformities.
- Treatment of depression and anxiety, commonly associated with cervical dystonia, is per standard practice.[3][3].
References[edit]
- ↑ Deutschländer AB, Wszolek ZK. DYT-GNAL. 2019 Jan 3. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535640/
- ↑ Deutschländer AB, Wszolek ZK. DYT-GNAL. 2019 Jan 3. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535640/
- ↑ Deutschländer AB, Wszolek ZK. DYT-GNAL. 2019 Jan 3. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535640/
NIH genetic and rare disease info[edit]
DYT-GNAL is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - DYT-GNAL
|
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian